OTCMKTS:TMSNY

Temenos Stock Forecast, Price & News

$147.28
0.00 (0.00 %)
(As of 09/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$145.74
$149.89
50-Day Range
$145.75
$162.90
52-Week Range
$105.07
$170.18
Volume9,605 shs
Average Volume13,517 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TMSNY News and Ratings via Email

Sign-up to receive the latest news and ratings for Temenos and its competitors with MarketBeat's FREE daily newsletter.


Temenos logo

About Temenos

Temenos AG is a holding company, which engages in the development, marketing, and sale of banking software systems. It operates through the Products and Services segments. The Product segment markets, licenses, and provides software solutions and subscription arrangements. The Services segment offers consulting and training activities. The company offers cloud-native, cloud-agnostic and Artificial Intelligence-driven front office, core banking, payments, and fund administration software products. Temenos was founded by George Koukis in 1993 and is headquartered in Geneva, Switzerland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.94 out of 5 stars

Analyst Opinion: 1.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Temenos (OTCMKTS:TMSNY) Frequently Asked Questions

Is Temenos a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Temenos in the last year. There are currently 3 sell ratings, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Temenos stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TMSNY, but not buy additional shares or sell existing shares.
View analyst ratings for Temenos
or view top-rated stocks.

What stocks does MarketBeat like better than Temenos?

Wall Street analysts have given Temenos a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Temenos wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Temenos?

Temenos saw a increase in short interest in August. As of August 31st, there was short interest totaling 3,400 shares, an increase of 36.0% from the August 15th total of 2,500 shares. Based on an average daily volume of 8,100 shares, the short-interest ratio is presently 0.4 days.
View Temenos' Short Interest
.

How has Temenos' stock price been impacted by Coronavirus?

Temenos' stock was trading at $140.78 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TMSNY stock has increased by 4.6% and is now trading at $147.2770.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TMSNY?

10 brokers have issued 12 month price objectives for Temenos' shares. Their forecasts range from $129.00 to $154.55. On average, they expect Temenos' stock price to reach $141.78 in the next twelve months. This suggests that the stock has a possible downside of 3.7%.
View analysts' price targets for Temenos
or view top-rated stocks among Wall Street analysts.

Who are Temenos' key executives?

Temenos' management team includes the following people:
  • Max Chuard, Chief Executive Officer
  • Alexa Guenoun, Chief Operating Officer
  • Panagiotis Spiliopoulos, Chief Financial Officer
  • Mark Winterburn, Chief Product and Technology Officer
  • Joaquin De Valenzuela Muley, SVP & Business Line Director-Temenos Infinity

Who are some of Temenos' key competitors?

What is Temenos' stock symbol?

Temenos trades on the OTCMKTS under the ticker symbol "TMSNY."

How do I buy shares of Temenos?

Shares of TMSNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Temenos' stock price today?

One share of TMSNY stock can currently be purchased for approximately $147.28.

How many employees does Temenos have?

Temenos employs 7,227 workers across the globe.

What is Temenos' official website?

The official website for Temenos is www.temenos.com.

Where are Temenos' headquarters?

Temenos is headquartered at rue Ecole-de-Chimie 2, Geneve, Geneve 1205.

How can I contact Temenos?

Temenos' mailing address is rue Ecole-de-Chimie 2, Geneve, Geneve 1205. The company can be reached via phone at (122) 708-1150.


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.